Chemical Component Summary

Name1,8-dihydroxyanthracene-9,10-dione
Identifiers1,8-dihydroxyanthracene-9,10-dione
FormulaC14 H8 O4
Molecular Weight240.21
TypeNON-POLYMER
Isomeric SMILESOc1cccc2C(=O)c3cccc(O)c3C(=O)c12
InChIInChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H
InChIKeyQBPFLULOKWLNNW-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count0
Bond Count28
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB04816 
NameDantron
Groups
  • approved
  • investigational
  • withdrawn
DescriptionWithdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.
Synonyms
  • 1,8-dihydroxyanthra-9,10-quinone
  • Chrysazin
  • Danthron
  • Dantron
  • 1,8-Dihydroxyanthrachinon
Brand Names
  • Regulex D Cap
  • Doss Tab
Categories
  • Alimentary Tract and Metabolism
  • Anthracenes
  • Contact Laxatives
  • Drugs for Constipation
  • Enemas
ATC-Code
  • A06AB03
  • A06AB53
  • A06AG03
CAS number117-10-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Serum albuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682